Pre-Clinical Safety and Efficacy Evaluation of Amytrap, a Novel Therapeutic to Treat Alzheimer's Disease.

J Alzheimers Dis Rep · 2019 · PMC6597960 · PMID 31259305

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost significantlyno p-value reported

The ratio was almost significantly reduced in the low dose whereas less significant reduction was observed in the high dose.

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.